Breaking News Instant updates and real-time market news.

VIA

Viacom

$39.20

0.65 (1.69%)

, VIAB

Viacom

$35.25

0.62 (1.79%)

06:19
12/22/16
12/22
06:19
12/22/16
06:19

Viacom CEO takes direct oversight of music, entertainment channels, Variety says

Following the departure of Viacom executive Doug Herzog, who has overseen Comedy Central and MTV, new CEO Bob Bakish will take on direct oversight of the cable channels in its music and entertainment group, Variety reports. Bakish confirmed in a memo to employees that Chris McCarthy, who oversees MTV, VH1 and Logo, will report to him directly, along with Comedy Central head Kent Alterman and Spike TV chief Kevin Kay. Reference Link

VIA

Viacom

$39.20

0.65 (1.69%)

VIAB

Viacom

$35.25

0.62 (1.79%)

  • 09

    Feb

  • 09

    Feb

VIA Viacom
$39.20

0.65 (1.69%)

12/12/16
JEFF
12/12/16
NO CHANGE
Target $65
JEFF
Jefferies doubts National Amusements would be interested in CBS sale
Jefferies analyst John Janedis contends that National Amusements dropping its call for CBS (CBS) to explore a merger with Viacom (VIA) potentially suggests a more independent Board structure than had been expected. He does not expect NAI to revisit a possible recombination for "at least another couple of years" and he also doubts the Redstones would look to sell CBS, adding he does not expect anything to come of "unsubstantiated press reports" regarding Verizon's supposed interest in CBS. The analyst keeps a Buy rating and $65 price target on CBS.
12/13/16
BMOC
12/13/16
UPGRADE
BMOC
Outperform
CBS upgraded on merger collapse at BMO Capital
As noted earlier, BMO Capital upgraded CBS (CBS) to Outperform from Market Perform. Analyst Daniel Salmon upgraded the stock after Viacom (VIA) announced that it was no longer pursuing a merger with CBS. Target to $70 from $63.
12/13/16
12/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CBS (CBS) upgraded to Outperform from Market Perform by BMO Capital analyst Daniel Salmon after Viacom (VIA) announced that it was no longer pursuing a merger. 2. Goldman analyst Matthew Borsch upgraded Molina Healthcare (MOH) to Buy and raised its price target to $65 from $59 citing attractive valuation and believes 2017 results will be more stable and stronger than expectations, particularly if ACA Medicaid coverage is maintained. 3. Janney Capital analyst Tyler Batory upgraded SeaWorld (SEAS) to Buy from Neutral based on his expectation for better performance from its Orlando park. 4. Goldman Sachs analyst Terence Flynn upgraded Ophthotech (OPHT) to Neutral after the stock ended yesterday down 86%. However, he sees a low likelihood that the company's trial testing a Fovista combo with Eylea or Avastin will be positive. 5. Achaogen (AKAO) upgraded to Buy from Hold at Needham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/13/16
12/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deutsche Bank analyst Bill Schmitz downgraded Procter & Gamble (PG) to Hold citing a lack of catalysts over the next few quarters. The analyst lowered his price target for P&G shares to $90 from $95 but remains positive on P&G's medium to long-term opportunity. Schmitz also downgraded Coca-Cola (KO) to Hold saying that while CEO James Quincey "is the right person for the turnaround job," near-term stock outperformance will be limited by investor migration out of staples, wellness related consumption headwinds and likely negative earnings revisions. The analyst cut his price target for Coca-Cola shares to $44 from $48. 2. Barclays analyst Karen Short downgraded GNC Holdings (GNC) to Underweight saying the company's recent strategy change and press reports indicating that at least some potential foreign buyers are not interested in the U.S. assets make a potential takeover unlikely. 3. RBC Capital downgraded Viacom (VIAB) to Underperform from Sector Perform after the company announced that it would no longer pursue a merger with CBS (CBS). Wedbush analyst James Dix also downgraded Viacom to Neutral after National Amusements withdrew support for a merger with CBS. 4. Craig-Hallum analyst Chad Bennett downgraded Model N (MODN) to Hold saying the "risks outweigh the benefits" following the company's acquisition of primary competitor Revitas. 5. Baird analyst Whit Mayo downgraded DaVita (DVA) to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VIAB Viacom
$35.25

0.62 (1.79%)

12/13/16
WEDB
12/13/16
DOWNGRADE
Target $39
WEDB
Neutral
Viacom downgraded to Neutral from Outperform at Wedbush
Wedbush analyst James Dix downgraded Viacom (VIAB) to Neutral after National Amusements withdrew support for a merger with CBS (CBS). The analyst now expects Viacom to trade in a "lower and more volatile" range given secular challenges to its TV network brands. He lowered his price target for the stock to $39 from $46. RBC Capital this morning also downgraded Viacom.
12/13/16
RBCM
12/13/16
DOWNGRADE
RBCM
Underperform
Viacom downgraded after deal collapse at RBC Capital
As noted earlier, RBC Capital downgraded Viacom (VIA) to Underperform from Sector Perform. Analyst Steven Cahall downgraded the stock after the company announced that it would no longer pursue a merger with CBS (CBS). Target to $30 from $44.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.